A composition for differentiating natural killer cell or enhancing natural killer cell activation containing tanshinone as active ingredient

• 1. 生产自然杀伤细胞的方法、由该方法生产的自然杀伤细胞以及包含该自然杀伤细胞的用于治疗癌症和感染性疾病的组合物 [P] . 中国专利： CN104204194B . 2018.08.03
• 2. 生产自然杀伤细胞的方法、由该方法生产的自然杀伤细胞以及包含该自然杀伤细胞的用于治疗癌症和感染性疾病的组合物 [P] . 中国专利： CN104204194A . 2014-12-10
• 3. A COMPOSITION FOR DIFFERENTIATING NATURAL KILLER CELL OR ENHANCING NATURAL KILLER CELL ACTIVATION CONTAINING TANSHINONE AS ACTIVE INGREDIENT [P] . 韩国专利： KR20130086820A . 2013-08-05

  机译： 区分坦桑酮作为活性成分的天然杀伤细胞或增强天然杀伤细胞活化的组合物

• 4. COMPOSITION CONTAINING TANSHINONE AS ACTIVE INGREDIENT, FOR INCREASING DIFFERENTIATION OR ACTIVITY OF NATURAL KILLER CELLS [P] . 世界知识产权组织专利： WO2013111969A1 . 2013-08-01

  机译： 包含丹参酮作为有效成分的组合物，用于增加天然杀伤细胞的分化或活性

• 5. A COMPOSITION CONTAINING TUMOR NECROSIS FACTOR-alpha; FOR DIFFERENTIATING NATURAL KILLER CELL AS AN ACTIVE INGREDIENT AND A METHOD OF DIFFERENTIATION USING THE SAME [P] . 韩国专利： KR101143369B1 . 2012-05-17

  机译： 包含肿瘤坏死因子-α的组合物;天然杀伤细胞作为活性成分的鉴别方法以及使用该方法进行鉴别的方法

• 1. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China [J] . Yanfen Feng, Huilan Rao, Yiyan Lei, 癌症（英文版） . 2017,第006期
• 2. Immune enhancement effect of an herb complex extract through the activation of natural killer cells and the regulation of cytokine levels in a cyclophosphamide-induced immunosuppression rat model [J] . Sung Min Woo, Min Jeung Kim, Ji Hyang Wee, 亚太热带医药杂志（英文版） . 2018,第012期
• 3. Trispecific killer engager 161519 enhances natural killer cell function and provides anti-tumor activity against CD19-positive cancers [J] . Ying Cheng, Xiaodong Zheng, Xuefu Wang, 癌症生物学与医学：英文版 . 2020,第004期
• 4. Natural killer T cell deficiency in active adult-onset Still's Disease: Correlation of deficiency of natural killer t cells with dysfunction of natural killer cells [J] . LeeS.-J., ChoY.-N., KimT.-J., Arthritis and Rheumatism . 2012,第9期
• 5. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells. [J] . Kusumi M, Yamashita T, Fujii T, Journal of Reproductive Immunology . 2006,第1a2期
• 6. A model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11+ granular lymphocytes with a natural killer-sensitive tumor cell, K562. [J] . J H Phillips, L L Lanier The Journal of Experomental Medicine . 1985,第6期
• 7. Imaging Lung Clearance of Radio labeled Tumor Cells to Study Mice with Normal, Activated or Depleted Natural Killer (NK) Cells [C] . P.V. Kulkarni, M. Bennett, A. Constantinescu, Application of Accelerators in Research and Industry . 2003
• 8. Characterization of cord blood natural killer cells: Implications for cord blood transplantation and insights into natural killer cell differentiation [D] . Gaddy, Jay A. 1998
• 9. A model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11+ granular lymphocytes with a natural killer-sensitive tumor cell K562 [O] . 1985
• 10. A model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11+ granular lymphocytes with a natural killer-sensitive tumor cell, K562 [O] . 1985

• 1. Autologous Natural Killer Cell/Natural Killer T Cell Immunotherapy of Malignant Diseases [J] . Aaron J. Smith ,John Oertle ,Dino Prato . 医学微生物学（英文） . 2014,第3期
• 2. Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells [J] . Qiu-Ju Han ,Yong-Liang Mu ,Hua-Jun Zhao . 世界胃肠病学杂志:英文版 . 2021,第24期
• 3. 气相单四极质谱(DSQTM Ⅱ)组合扫描技术用于多组分化合物的同时分析 [C] . 芦苓 ,张伟国 . 2007年全国有机质谱学术交流会 . 2007
• 4. HIV/HCV共感染者自然杀伤细胞表面活化性与抑制性受体表达研究 [A] . 赵鹏 . 2011